Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis
- Resource Type
- Article
- Authors
- Faleck, David M.; Winters, Adam; Chablaney, Shreya; Shashi, Preeti; Meserve, Joseph; Weiss, Aaron; Aniwan, Satimai; Koliani-Pace, Jenna L.; Kochhar, Gursimran; Boland, Brigid S.; Singh, Siddharth; Hirten, Robert; Shmidt, Eugenia; Kesar, Varun; Lasch, Karen; Luo, Michelle; Bohm, Matthew; Varma, Sashidhar; Fischer, Monika; Hudesman, David; Chang, Shannon; Lukin, Dana; Sultan, Keith; Swaminath, Arun; Gupta, Nitin; Siegel, Corey A.; Shen, Bo; Sandborn, William J.; Kane, Sunanda; Loftus, Edward V., Jr.; Sands, Bruce E.; Colombel, Jean-Frederic; Dulai, Parambir S.; Ungaro, Ryan
- Source
- In Clinical Gastroenterology and Hepatology November 2019 17(12):2497-2505
- Subject
- Language
- ISSN
- 1542-3565